Page results
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
UCLH will play a vital role in a new respiratory virus study.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
The Royal National ENT Voice Centre is a national and international multidisciplinary centre for voice disorders. The voice clinic at the RNENT is one of the oldest in the UK.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
File results
-
FOI/2024/0061 - 24 hour waits at A&E from 2019 to 2023
-
FOI/2024/0063 - Clinicians and nurses trained in treating patients with sodium nitrite poisoning
-
FOI/2024/0064 - Communications and public relations spend for 2020/21-2022/23
-
FOI/2024/0066 - Amputations due to medical errors 2020-2023
-
FOI/2024/0070 - Treatments for metastatic/ adjuvant melanoma, colorectal and lung cancers
-
FOI/2024/0075 - Blood products used at Trust
-
FOI/2024/0076 - Patient Portal contract and supplier
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0079 - Water procurement
-
FOI/2024/0080 - Patient treatment for botched non-surgical procedures